Novartis AG
Novartis's Climate Target Data Preview
As of 2024, Novartis has disclosed 3 climate targets aimed at reducing its greenhouse gas (GHG) emissions. These include 3 absolute reduction targets, signaling the company’s commitment to managing and lowering its carbon footprint over time. The targets span various emissions scopes and time horizons, offering insight into Novartis ’s climate strategy, ambition level, and alignment with global decarbonization goals.
| Target Type | Scope of Target | Unit | Target | Target Year |
|---|---|---|---|---|
Absolute-based Target | Scope 1 - Total, Scope 2 - Total | Metric Tonnes of CO2 equivalent (mtCO2e) | Copy restricted. Please purchase to unlock this data.  | 2030 |
Absolute-based Target | Scope 3 - Total | Metric Tonnes of CO2 equivalent (mtCO2e) | Copy restricted. Please purchase to unlock this data.  | 2030 |
Absolute-based Target | Scope 1 - Total, Scope 2 - Total, Scope 3 - Total | Metric Tonnes of CO2 equivalent (mtCO2e) | Copy restricted. Please purchase to unlock this data. | 2040 |
This table provides a simplified preview of selected climate targets data points. To access the complete dataset with full disclosures, detailed breakdowns, and source traceability, create a free account to view purchase options.
Insights into Novartis's Greenhouse Gas Emissions Pathways
As of 2024, Novartis has set greenhouse gas (GHG) emissions reduction targets that cover both its operational emissions (Scope 1 and 2) and value chain emissions (Scope 3), offering a comprehensive view of its total carbon footprint.
Does Novartis have a target to reduce the emissions from its operations?
As of 2024, Novartis has set a target to reduce its operational greenhouse gas (GHG) emissions, specifically those from Scope 1 and Scope 2 sources.
Novartis's most ambitious operational target is to reduce these emissions by 90% by 2030, compared to a baseline of 365,336 Metric Tonnes of CO2 equivalent (mtCO2e) in 2022.
As of 2024, Novartis is ahead of schedule on its operational emissions reduction target, having achieved 40.3% of the planned reduction.
Novartis's Operational (Scope 1+2) Emissions Pathway
Does Novartis have a target to reduce the emissions from its value chain?
As of 2024, Novartis has set a target to reduce its value chain greenhouse gas (GHG) emissions, covering 1 out of the 15 Scope 3 categories defined by the GHG Protocol.
Novartis's most ambitious value chain target is to reduce these emissions by 42% by 2030, compared to a baseline of 4,829,157 Metric Tonnes of CO2 equivalent (mtCO2e) in 2022.
As of 2024, Novartis is ahead of schedule on its value chain emissions reduction target, having achieved 31.83% of the planned reduction.
Novartis's Value Chain (Scope 3) Emissions Pathway
Does Novartis have a target to reduce its total carbon footprint?
As of 2024, Novartis has set a target to reduce its total carbon footprint, specifically those from Scope 1, Scope 2 and Scope 3 sources.
Novartis's most ambitious carbon footprint target is to reduce its scope 1, 2 and 3 emissions from a baseline of 5,237,736 Metric Tonnes of CO2 equivalent (mtCO2e) in 2022, by 90% by 2040.
As of 2024, Novartis is ahead of schedule on its total carbon footprint reduction target, having achieved 16.62% of the planned reduction.